Literature DB >> 22819050

A strategy for efficient discovery of new natural compounds by integrating orthogonal column chromatography and liquid chromatography/mass spectrometry analysis: Its application in Panax ginseng, Panax quinquefolium and Panax notoginseng to characterize 437 potential new ginsenosides.

Wen-zhi Yang1, Min Ye, Xue Qiao, Chun-fang Liu, Wen-juan Miao, Tao Bo, Hai-yan Tao, De-an Guo.   

Abstract

To discover new natural compounds from herbal medicines tends to be more and more difficult. In this paper, a strategy integrating orthogonal column chromatography and liquid chromatography/mass spectrometry (LC/MS) analysis was proposed, and was applied for rapid discovery of new ginsenosides from Panax ginseng (PG), Panax quinquefolium (PQ), and Panax notoginseng (PN). The ginsenosides extracts were fractionated by MCI gel×silica gel orthogonal column chromatography. The fractions were then separated on a C(18) HPLC column, eluted with a three-component mobile phase (CH(3)CN/CH(3)OH/3mM CH(3)COONH(4)H(2)O), and detected by electrospray ionization tandem mass spectrometry. The structures of unknown ginsenosides were elucidated by analyzing negative and positive ion mass spectra, which provided complementary information on the sapogenins and oligosaccharide chains, respectively. A total of 623 comprising 437 potential new ginsenosides were characterized from the ethanol extracts of PG, PQ and PN. New acylations, diversified saccharide chains and C-17 side chains constituted novelty of the newly identified ginsenosides. An interpretation guideline was proposed for structural characterization of unknown ginsenosides by LC/MS. To confirm reliability of this strategy, two targeted unknown trace ginsenosides were obtained in pure form by LC/MS-guided isolation. Based on extensive NMR spectroscopic analysis and other techniques, they were identified as 3-O-[6-O-(E)-butenoyl-β-D-glucopyranosyl(1,2)-β-D-glucopyranosyl]-20(S)-protopanaxadiol-20-O-β-D-glucopyranosyl(1,6)-β-D-glucopyranoside (named ginsenoside IV) and 3-O-β-D-glucopyranosyl(1,2)-β-D-glucopyranosyl-3β,12β,20(S),24(R)-tetra hydroxy-dammar-25-ene-20-O-β-D-glucopyranosyl(1,6)-β-D-glucopyranoside (ginsenoside V), respectively. The fully established structures were consistent with the MS-oriented structural elucidation. This study expanded our understanding on ginsenosides of Panax species, and the proposed strategy was proved efficient and reliable in the discovery of new minor compounds from herbal extracts.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22819050     DOI: 10.1016/j.aca.2012.06.017

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  30 in total

1.  Qualitative analysis of xinyue capsules by high-performance liquid chromatography: Preliminary evaluation of drug quality in a Sino-Austrian joint study.

Authors:  Mei Xue; Lin Yang; Da-zhuo Shi; Christian Radauer; Heimo Breiteneder; Yan Ma
Journal:  Chin J Integr Med       Date:  2015-11-03       Impact factor: 1.978

2.  Multiple circulating saponins from intravenous ShenMai inhibit OATP1Bs in vitro: potential joint precipitants of drug interactions.

Authors:  Olajide E Olaleye; Wei Niu; Fei-Fei Du; Feng-Qing Wang; Fang Xu; Salisa Pintusophon; Jun-Lan Lu; Jun-Ling Yang; Chuan Li
Journal:  Acta Pharmacol Sin       Date:  2018-10-16       Impact factor: 6.150

3.  Transcriptome analysis of Panax zingiberensis identifies genes encoding oleanolic acid glucuronosyltransferase involved in the biosynthesis of oleanane-type ginsenosides.

Authors:  Qing-Yan Tang; Geng Chen; Wan-Ling Song; Wei Fan; Kun-Hua Wei; Si-Mei He; Guang-Hui Zhang; Jun-Rong Tang; Ying Li; Yuan Lin; Sheng-Chao Yang
Journal:  Planta       Date:  2018-09-15       Impact factor: 4.116

4.  An Integrated Strategy for Global Qualitative and Quantitative Profiling of Traditional Chinese Medicine Formulas: Baoyuan Decoction as a Case.

Authors:  Xiaoli Ma; Xiaoyu Guo; Yuelin Song; Lirui Qiao; Wenguang Wang; Mingbo Zhao; Pengfei Tu; Yong Jiang
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

5.  Intervention Effects of Atorvastatin Combined with Panax notoginseng Saponins on Rats with Atherosclerosis Complicated with Hepatic Injury.

Authors:  Qing-Fang Jiang; Min-Yi Huang; Kang-Yuan Wu; Jie-Ling Weng; Rong-Gui Deng; Xin-Jie Xu; Jian-Pei Xu; Tao Jiang
Journal:  Pharmacogn Mag       Date:  2017-07-19       Impact factor: 1.085

6.  A Bioactive Chemical Markers Based Strategy for Quality Assessment of Botanical Drugs: Xuesaitong Injection as a Case Study.

Authors:  Zhenzhong Yang; Qing Shao; Zhiwei Ge; Ni Ai; Xiaoping Zhao; Xiaohui Fan
Journal:  Sci Rep       Date:  2017-05-25       Impact factor: 4.379

7.  177 Saponins, Including 11 New Compounds in Wild Ginseng Tentatively Identified via HPLC-IT-TOF-MSn, and Differences among Wild Ginseng, Ginseng under Forest, and Cultivated Ginseng.

Authors:  Chao-Qun Wang; Li-Wei Yi; Lin Zhao; Yu-Zhen Zhou; Fang Guo; Yu-Shu Huo; Da-Qing Zhao; Feng Xu; Xuan Wang; Shao-Qing Cai
Journal:  Molecules       Date:  2021-06-02       Impact factor: 4.411

8.  Chemical Variations among Shengmaisan-Based TCM Patent Drugs by Ultra-High Performance Liquid Chromatography Coupled with Hybrid Quadrupole Orbitrap Mass Spectrometry.

Authors:  Lulu Xu; Zhanpeng Shang; Yungang Tian; Ming Xiong; Dilaram Nijat; Yuan Wang; Xue Qiao; Min Ye
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

9.  Biotransformation of ginsenoside Rb1 via the gypenoside pathway by human gut bacteria.

Authors:  Hong Shen; Weng-Im Leung; Jian-Qing Ruan; Song-Lin Li; Jacky Pui-Cheong Lei; Yi-Tao Wang; Ru Yan
Journal:  Chin Med       Date:  2013-11-23       Impact factor: 5.455

10.  Rapid discovery and identification of anti-inflammatory constituents from traditional Chinese medicine formula by activity index, LC-MS, and NMR.

Authors:  Shufang Wang; Haiqiang Wang; Yining Liu; Yi Wang; Xiaohui Fan; Yiyu Cheng
Journal:  Sci Rep       Date:  2016-08-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.